Target intelligence / Profile preview

SUMO2 pseudogene 16 (SUMO2P16)

Target
SUMO2P16
Molecular classification
Other (Pseudogene)
01

Overview

SUMO2 pseudogene 16 is a non-functional pseudogene originating from the Small Ubiquitin-like Modifier 2 (SUMO2) gene. It does not encode a functional protein, enzyme, receptor, or transporter, and is not considered a therapeutic target. Pseudogenes like SUMO2P16 are typically the result of ancient gene duplication or retrotransposition events and do not have biological activity. The parent gene, SUMO2, participates in the post-translational modification of proteins, playing critical roles in nuclear transport, transcriptional regulation, apoptosis, and protein stability[1][4]. In contrast, SUMO2 pseudogene 16 (and other SUMO2 pseudogenes) do not contribute to these functions, nor are they involved in human disease or drug interactions. If you need details about the functional SUMO2 gene (not the pseudogene), further information is available, including its role in protein modification, cell cycle, and disease associations[1][2][4][6].

Other names
SUMO2P16Small ubiquitin-like modifier 2 pseudogene 16

Beyond the preview

Go deeper on SUMO2 pseudogene 16 (SUMO2P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SUMO2 pseudogene 16 (SUMO2P16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call